State Street Corp Biocryst Pharmaceuticals Inc Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 17,477,344 shares of BCRX stock, worth $112 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,477,344
Previous 12,777,003
36.79%
Holding current value
$112 Million
Previous $76.5 Million
16.01%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BCRX
# of Institutions
256Shares Held
182MCall Options Held
839KPut Options Held
816K-
Black Rock Inc. New York, NY18.4MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.7MShares$113 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY13.1MShares$83.7 Million0.8% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$64.9 Million0.65% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.53MShares$41.8 Million3.48% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.19B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...